NO319988B1 - Polypeptid omfattende et fimbralt protein fra Bordetella Bronchiseptica, polynukleotid og ekspresjonsvektor som koder for et slikt protein, samt en vaksine eller farmasoytisk preparat for a bekjempe B. Bronchiseptica infeksjoner. - Google Patents
Polypeptid omfattende et fimbralt protein fra Bordetella Bronchiseptica, polynukleotid og ekspresjonsvektor som koder for et slikt protein, samt en vaksine eller farmasoytisk preparat for a bekjempe B. Bronchiseptica infeksjoner. Download PDFInfo
- Publication number
- NO319988B1 NO319988B1 NO19950582A NO950582A NO319988B1 NO 319988 B1 NO319988 B1 NO 319988B1 NO 19950582 A NO19950582 A NO 19950582A NO 950582 A NO950582 A NO 950582A NO 319988 B1 NO319988 B1 NO 319988B1
- Authority
- NO
- Norway
- Prior art keywords
- bronchiseptica
- protein
- gene
- fimbrial
- dna
- Prior art date
Links
- 241000588779 Bordetella bronchiseptica Species 0.000 title claims abstract description 67
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 39
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 36
- 229920001184 polypeptide Polymers 0.000 title claims abstract description 33
- 108091033319 polynucleotide Proteins 0.000 title claims abstract description 19
- 102000040430 polynucleotide Human genes 0.000 title claims abstract description 19
- 239000002157 polynucleotide Substances 0.000 title claims abstract description 19
- 208000015181 infectious disease Diseases 0.000 title claims abstract description 17
- 229960005486 vaccine Drugs 0.000 title claims abstract description 15
- 239000013604 expression vector Substances 0.000 title claims description 6
- 239000000825 pharmaceutical preparation Substances 0.000 title claims description 4
- 108090000623 proteins and genes Proteins 0.000 title abstract description 85
- 102000004169 proteins and genes Human genes 0.000 title abstract description 21
- 101710177917 Fimbrial protein Proteins 0.000 claims abstract description 24
- 239000012634 fragment Substances 0.000 claims description 41
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 7
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 238000006467 substitution reaction Methods 0.000 claims description 2
- 241000282472 Canis lupus familiaris Species 0.000 abstract description 11
- 241001465754 Metazoa Species 0.000 abstract description 7
- 238000002360 preparation method Methods 0.000 abstract description 3
- 241000282898 Sus scrofa Species 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 32
- 239000000523 sample Substances 0.000 description 24
- 238000000034 method Methods 0.000 description 22
- 239000013612 plasmid Substances 0.000 description 20
- 238000009396 hybridization Methods 0.000 description 18
- 229960000318 kanamycin Drugs 0.000 description 18
- 241000894006 Bacteria Species 0.000 description 17
- 229930027917 kanamycin Natural products 0.000 description 17
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical group O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 17
- 229930182823 kanamycin A Natural products 0.000 description 17
- 238000004520 electroporation Methods 0.000 description 15
- 241000588724 Escherichia coli Species 0.000 description 14
- 235000018102 proteins Nutrition 0.000 description 14
- 239000013598 vector Substances 0.000 description 14
- 239000013611 chromosomal DNA Substances 0.000 description 13
- 238000002474 experimental method Methods 0.000 description 13
- 230000001580 bacterial effect Effects 0.000 description 11
- 241000588807 Bordetella Species 0.000 description 10
- 241000588832 Bordetella pertussis Species 0.000 description 10
- 241000699670 Mus sp. Species 0.000 description 10
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 10
- 239000002953 phosphate buffered saline Substances 0.000 description 10
- 101150033489 fimX gene Proteins 0.000 description 9
- 108091008146 restriction endonucleases Proteins 0.000 description 9
- 101710154643 Filamentous hemagglutinin Proteins 0.000 description 8
- 241000282887 Suidae Species 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- UTPGRZGMQVAYAA-UHFFFAOYSA-N 4-fluoro-n-methyl-n-[4-[6-(methylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]benzamide Chemical compound C1=NC(NC)=CC(C=2N=C(SC=2)N(C)C(=O)C=2C=CC(F)=CC=2)=N1 UTPGRZGMQVAYAA-UHFFFAOYSA-N 0.000 description 7
- 229920001817 Agar Polymers 0.000 description 7
- 239000008272 agar Substances 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 239000002773 nucleotide Substances 0.000 description 7
- 125000003729 nucleotide group Chemical group 0.000 description 7
- 101100120321 Bordetella pertussis (strain Tohama I / ATCC BAA-589 / NCTC 13251) fimX gene Proteins 0.000 description 6
- 229910019142 PO4 Inorganic materials 0.000 description 6
- 241000700605 Viruses Species 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 6
- 239000010452 phosphate Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000002105 Southern blotting Methods 0.000 description 5
- 238000003776 cleavage reaction Methods 0.000 description 5
- 238000010367 cloning Methods 0.000 description 5
- 230000002163 immunogen Effects 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 210000002345 respiratory system Anatomy 0.000 description 5
- 230000007017 scission Effects 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 241000588851 Bordetella avium Species 0.000 description 4
- 101100446841 Bordetella pertussis (strain Tohama I / ATCC BAA-589 / NCTC 13251) fim2 gene Proteins 0.000 description 4
- 108091026890 Coding region Proteins 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 210000001989 nasopharynx Anatomy 0.000 description 4
- 210000001331 nose Anatomy 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 210000003437 trachea Anatomy 0.000 description 4
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 3
- 241000588780 Bordetella parapertussis Species 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 241000204031 Mycoplasma Species 0.000 description 3
- 108020004511 Recombinant DNA Proteins 0.000 description 3
- 239000011543 agarose gel Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 210000004102 animal cell Anatomy 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 230000028993 immune response Effects 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 238000002255 vaccination Methods 0.000 description 3
- 239000000304 virulence factor Substances 0.000 description 3
- 230000007923 virulence factor Effects 0.000 description 3
- 239000001987 Bordet-Gengou agar Substances 0.000 description 2
- 208000018150 Bordetella infection Diseases 0.000 description 2
- 241000589875 Campylobacter jejuni Species 0.000 description 2
- 239000003298 DNA probe Substances 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 239000006142 Luria-Bertani Agar Substances 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 240000000220 Panda oleosa Species 0.000 description 2
- 235000016496 Panda oleosa Nutrition 0.000 description 2
- 241000606856 Pasteurella multocida Species 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 201000005702 Pertussis Diseases 0.000 description 2
- 108010081690 Pertussis Toxin Proteins 0.000 description 2
- 241000276498 Pollachius virens Species 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 2
- 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- AFYNADDZULBEJA-UHFFFAOYSA-N bicinchoninic acid Chemical compound C1=CC=CC2=NC(C=3C=C(C4=CC=CC=C4N=3)C(=O)O)=CC(C(O)=O)=C21 AFYNADDZULBEJA-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 210000004081 cilia Anatomy 0.000 description 2
- 210000000254 ciliated cell Anatomy 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000001493 electron microscopy Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 229940031626 subunit vaccine Drugs 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 description 2
- 229940126580 vector vaccine Drugs 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- QGXCOCVWIKYPKW-UHFFFAOYSA-N 3-ethyl-2h-1,3-benzothiazole-6-sulfinic acid Chemical compound OS(=O)C1=CC=C2N(CC)CSC2=C1 QGXCOCVWIKYPKW-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 201000008283 Atrophic Rhinitis Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 101100446842 Bordetella pertussis (strain Tohama I / ATCC BAA-589 / NCTC 13251) fim3 gene Proteins 0.000 description 1
- 241000589893 Brachyspira hyodysenteriae Species 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241000589876 Campylobacter Species 0.000 description 1
- 241000282421 Canidae Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000710777 Classical swine fever virus Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 102000000634 Cytochrome c oxidase subunit IV Human genes 0.000 description 1
- 108050008072 Cytochrome c oxidase subunit IV Proteins 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 108020003215 DNA Probes Proteins 0.000 description 1
- 108010041986 DNA Vaccines Proteins 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 101710110818 Dermonecrotic toxin Proteins 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000701533 Escherichia virus T4 Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 241000424725 Heide Species 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- 241001430197 Mollicutes Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 1
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 1
- 241000125945 Protoparvovirus Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 206010039088 Rhinitis atrophic Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 101710157507 Serotype 2 fimbrial subunit Proteins 0.000 description 1
- 101710089230 Serotype 3 fimbrial subunit Proteins 0.000 description 1
- 241000194021 Streptococcus suis Species 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000701093 Suid alphaherpesvirus 1 Species 0.000 description 1
- 108010008038 Synthetic Vaccines Proteins 0.000 description 1
- 239000008049 TAE buffer Substances 0.000 description 1
- 241000711484 Transmissible gastroenteritis virus Species 0.000 description 1
- 241000589884 Treponema pallidum Species 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- HGEVZDLYZYVYHD-UHFFFAOYSA-N acetic acid;2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid Chemical compound CC(O)=O.OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O HGEVZDLYZYVYHD-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 102000030621 adenylate cyclase Human genes 0.000 description 1
- 108060000200 adenylate cyclase Proteins 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 1
- 229940125717 barbiturate Drugs 0.000 description 1
- HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000007465 bordet-gengou-medium Substances 0.000 description 1
- 210000000424 bronchial epithelial cell Anatomy 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000002729 catgut Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 108010052305 exodeoxyribonuclease III Proteins 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- -1 fimbriae Proteins 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 239000003228 hemolysin Substances 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 229920000140 heteropolymer Polymers 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000009851 immunogenic response Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000012261 overproduction Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229940051027 pasteurella multocida Drugs 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- AVFBYUADVDVJQL-UHFFFAOYSA-N phosphoric acid;trioxotungsten;hydrate Chemical compound O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.OP(O)(O)=O AVFBYUADVDVJQL-UHFFFAOYSA-N 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229940124551 recombinant vaccine Drugs 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 239000013605 shuttle vector Substances 0.000 description 1
- 210000004894 snout Anatomy 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 210000001944 turbinate Anatomy 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP92202525 | 1992-08-18 | ||
| PCT/NL1993/000161 WO1994004683A1 (fr) | 1992-08-18 | 1993-07-28 | VACCIN CONTRE $i(BORDETELLA BRONCHISEPTICA) |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO950582D0 NO950582D0 (no) | 1995-02-16 |
| NO950582L NO950582L (no) | 1995-02-16 |
| NO319988B1 true NO319988B1 (no) | 2005-10-10 |
Family
ID=8210860
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19950582A NO319988B1 (no) | 1992-08-18 | 1995-02-16 | Polypeptid omfattende et fimbralt protein fra Bordetella Bronchiseptica, polynukleotid og ekspresjonsvektor som koder for et slikt protein, samt en vaksine eller farmasoytisk preparat for a bekjempe B. Bronchiseptica infeksjoner. |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US5939064A (fr) |
| EP (1) | EP0656948B1 (fr) |
| JP (1) | JPH08500734A (fr) |
| AT (1) | ATE263244T1 (fr) |
| CA (1) | CA2142712C (fr) |
| CZ (1) | CZ285307B6 (fr) |
| DE (1) | DE69333467T2 (fr) |
| FI (1) | FI113242B (fr) |
| HU (1) | HU219819B (fr) |
| NO (1) | NO319988B1 (fr) |
| PL (1) | PL307505A1 (fr) |
| RU (1) | RU2129611C1 (fr) |
| SK (1) | SK21495A3 (fr) |
| WO (1) | WO1994004683A1 (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2646776B1 (fr) | 1989-05-12 | 1994-06-03 | Pasteur Institut | Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella |
| FR2728170A1 (fr) * | 1994-12-15 | 1996-06-21 | Pasteur Institut | Vaccin de type acellulaire anti-bordetella |
| US6475754B1 (en) * | 1999-05-14 | 2002-11-05 | University Of Tennessee Research Corporation | Polynucleotides encoding Bordatella bronchiseptica fimbrial proteins (FimN), vectors, and expression systems therefor |
| US7435422B2 (en) * | 2004-01-15 | 2008-10-14 | Intervet International B.V. | Non-animal origin stabilizers and processes for producing the same |
| US7521059B2 (en) * | 2004-06-14 | 2009-04-21 | Fenwick Bradley W | Kennel cough vaccine |
| BRPI0519923A8 (pt) * | 2004-12-17 | 2018-01-23 | De Staat Der Nederlanden Vertegenwoordigd Door De Mini Van Vws | polipeptídeo, seqüência de dna, vetor de dna, anticorpo, bactéria, método para produzir lps parcialmente 3-0-desacilado, composição, usos da bactéria, e de lps de bordetella isolado compreendendo lps pelo menos parcialmente 3-0-desacilado, vacina, e, método in vitro para a desacilação de lps gram-negativo ou de composições compreendendo lps gram-negativo, e, para induzir uma resposta imune contra bordetella. |
| CN112375127B (zh) * | 2020-11-25 | 2022-09-09 | 江苏省农业科学院 | 一种用作支气管败血波氏菌病疫苗的重组蛋白及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU575086B2 (en) * | 1983-11-07 | 1988-07-21 | Syntex (U.S.A.) Inc. | Bordetella bronchiseptica pili subunit protein and vaccine |
| DK594084A (da) * | 1984-12-12 | 1986-06-13 | Novo Industri As | Fremgangsmaade til stabilisering af extra-chromosomale elementer i bakterier under dyrkning |
| IT1223579B (it) * | 1987-12-22 | 1990-09-19 | Eniricerche Spa | Clonaggio e sequenziamento del gene codificante per una nuova subunita' pilinica di bordetella pertussis |
| IT1231961B (it) * | 1989-09-22 | 1992-01-16 | Eniricerche Spa | Clonaggio del gene codificante la subunita' pilinica fim3 di bordetella pertussis. |
-
1993
- 1993-07-28 US US08/381,881 patent/US5939064A/en not_active Expired - Lifetime
- 1993-07-28 CZ CZ95410A patent/CZ285307B6/cs not_active IP Right Cessation
- 1993-07-28 CA CA002142712A patent/CA2142712C/fr not_active Expired - Lifetime
- 1993-07-28 AT AT93919704T patent/ATE263244T1/de not_active IP Right Cessation
- 1993-07-28 JP JP6506121A patent/JPH08500734A/ja active Pending
- 1993-07-28 PL PL93307505A patent/PL307505A1/xx unknown
- 1993-07-28 DE DE69333467T patent/DE69333467T2/de not_active Expired - Lifetime
- 1993-07-28 HU HU9500491A patent/HU219819B/hu unknown
- 1993-07-28 EP EP93919704A patent/EP0656948B1/fr not_active Expired - Lifetime
- 1993-07-28 RU RU95107705A patent/RU2129611C1/ru active
- 1993-07-28 WO PCT/NL1993/000161 patent/WO1994004683A1/fr active IP Right Grant
-
1995
- 1995-02-16 NO NO19950582A patent/NO319988B1/no not_active IP Right Cessation
- 1995-02-16 SK SK214-95A patent/SK21495A3/sk not_active IP Right Cessation
- 1995-02-17 FI FI950740A patent/FI113242B/fi not_active IP Right Cessation
-
1999
- 1999-03-30 US US09/281,221 patent/US6284256B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO1994004683A1 (fr) | 1994-03-03 |
| NO950582D0 (no) | 1995-02-16 |
| CA2142712C (fr) | 2004-01-06 |
| US5939064A (en) | 1999-08-17 |
| CA2142712A1 (fr) | 1994-03-03 |
| RU95107705A (ru) | 1997-03-27 |
| FI950740A (fi) | 1995-02-17 |
| RU2129611C1 (ru) | 1999-04-27 |
| EP0656948A1 (fr) | 1995-06-14 |
| DE69333467D1 (de) | 2004-05-06 |
| NO950582L (no) | 1995-02-16 |
| HU9500491D0 (en) | 1995-04-28 |
| US6284256B1 (en) | 2001-09-04 |
| CZ285307B6 (cs) | 1999-07-14 |
| EP0656948B1 (fr) | 2004-03-31 |
| SK21495A3 (en) | 1995-07-11 |
| DE69333467T2 (de) | 2005-01-20 |
| CZ41095A3 (en) | 1995-08-16 |
| FI950740A0 (fi) | 1995-02-17 |
| PL307505A1 (en) | 1995-05-29 |
| FI113242B (fi) | 2004-03-31 |
| HU219819B (hu) | 2001-08-28 |
| JPH08500734A (ja) | 1996-01-30 |
| ATE263244T1 (de) | 2004-04-15 |
| HUT70984A (en) | 1995-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Luo et al. | Cloning and characterization of the major outer membrane protein gene (ompH) of Pasteurella multocida X-73 | |
| Ruffolo et al. | Cloning, sequencing, expression, and protective capacity of the oma87 gene encoding the Pasteurella multocida 87-kilodalton outer membrane antigen | |
| Gilmore Jr et al. | The 120 kilodalton outer membrane protein (rOmp B) of Rickettsia rickettsii is encoded by an unusually long open reading frame: evidence for protein processing from a large precursor | |
| JP3380559B2 (ja) | ヘリコバクター・ピロリ抗原及びワクチン組成物 | |
| Mooi et al. | Characterization of fimbrial subunits from Bordetella species | |
| RU2556813C2 (ru) | Живые аттенуированные вакцины | |
| IE903377A1 (en) | Vaccine against lyme disease | |
| CN107529534B (zh) | 一种副鸡禽杆菌的保护性抗原、及其表达和应用 | |
| Kasten et al. | Pasteurella multocida produces a protein with homology to the P6 outer membrane protein of Haemophilus influenzae | |
| NZ234933A (en) | Vaccine against e.coli infection and toxin therefor derived from flagella of a single e.coli strain | |
| Singh et al. | Molecular heterogeneity of plpE gene in Indian isolates of Pasteurella multocida and expression of recombinant PlpE in vaccine strain of P. multocida serotype B: 2 | |
| JP3236610B2 (ja) | 豚胸膜肺炎用ワクチン | |
| NO319988B1 (no) | Polypeptid omfattende et fimbralt protein fra Bordetella Bronchiseptica, polynukleotid og ekspresjonsvektor som koder for et slikt protein, samt en vaksine eller farmasoytisk preparat for a bekjempe B. Bronchiseptica infeksjoner. | |
| EP2916863B1 (fr) | Vaccins de mannheimia haemolytica atténués et procédés de fabrication et d'utilisation | |
| JP2023503057A (ja) | ヘモフィルス・パラスイスに対する新規ワクチン | |
| JP2023503058A (ja) | ヘモフィルス・パラスイスに対する新規ワクチン | |
| KR20060129163A (ko) | 로소니아 인트라셀룰라리스 서브유닛 백신 | |
| JP2006500914A (ja) | ブタ赤痢（Ｂｒａｃｈｙｓｐｉｒａｈｙｏｄｙｓｅｎｔｅｒｉａｅ）ワクチン | |
| JPH10290695A (ja) | アクチノバシラス・プレウロニューモニアの弱毒化生菌 | |
| Smerdou et al. | A continuous epitope from transmissible gastroenteritis virus S protein fused to E. coli heat-labile toxin B subunit expressed by attenuated Salmonella induces serum and secretory immunity | |
| MXPA02010418A (es) | Vacuna de leucotoxina de fusobacterium necrophorum recombinante y preparacion de la misma. | |
| Liu et al. | Cloning, expression, and characterization of TonB2 from Actinobacillus pleuropneumoniae and potential use as an antigenic vaccine candidate and diagnostic marker | |
| RU2822516C1 (ru) | Новая вакцина против haemophilus parasuis | |
| EP1350796A1 (fr) | Bactéries Gram négatives atténuées | |
| BRAMBILA et al. | Two outer membrane lipoproteins from histophilus somni are Immunogenic in rabbits and sheep and induce protection against bacterial challenge in mice |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |